APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesalazine API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mesalazine API Market Outlook and Growth Opportunities 2026

28 December 2025190 pages

Choose your research edition.

Industry ResearchMesalazine API Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalazine API Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Mesalazine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalazine API Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalazine API Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Mesalazine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mesalazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mesalazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mesalazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mesalazine API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mesalazine API market include YC Biotech (Jiangsu), Lianyungang Fengheng Biopharm, Hangzhou Brother, Syntese A/S, PharmaZell, Lasa Loboratory, Ishita Active Pharma Ingredients, Ipca Laboratories and Erregierre SpA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mesalazine API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesalazine API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesalazine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mesalazine API market size, projected growth trends, production technologies, key applications, and end-use industries.

Mesalazine API Segment by Company

YC Biotech (Jiangsu)

Lianyungang Fengheng Biopharm

Hangzhou Brother

Syntese A/S

PharmaZell

Lasa Loboratory

Ishita Active Pharma Ingredients

Ipca Laboratories

Erregierre SpA

Divis Laboratories

CTX Lifescience

Corden Pharma Bergamo

Chemi SpA

Cambrex Corporation

Mesalazine API Segment by Type

Purity ≥ 99%

Purity ≥ 98%

Purity ≥ 97%

Mesalazine API Segment by Application

Suppository

Tablets

Granule

Capsules

Enema

Others

Mesalazine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mesalazine API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mesalazine API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mesalazine API significant trends, drivers, influence factors in global and regions.

6. To analyze Mesalazine API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalazine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mesalazine API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mesalazine API industry.

Chapter 3: Detailed analysis of Mesalazine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mesalazine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mesalazine API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mesalazine API Industry Trends Table 2. Mesalazine API Industry Drivers Table 3. Mesalazine API Industry Opportunities and Challenges Table 4. Mesalazine API Industry Restraints Table 5. Global Mesalazine API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mesalazine API Revenue Share by Company (2021-2026) Table 7. Global Mesalazine API Sales Volume by Company (t) & (2021-2026) Table 8. Global Mesalazine API Sales Volume Share by Company (2021-2026) Table 9. Global Mesalazine API Average Price (USD/kg) of Company (2021-2026) Table 10. Global Mesalazine API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mesalazine API Key Company Manufacturing Base & Headquarters Table 12. Global Mesalazine API Company, Product Type & Application Table 13. Global Mesalazine API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mesalazine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≥ 99% Table 18. Significant Companies of Purity ≥ 98% Table 19. Significant Companies of Purity ≥ 97% Table 20. Global Mesalazine API Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Mesalazine API Sales Volume by Type (2021-2026) & (t) Table 22. Global Mesalazine API Sales Volume by Type (2027-2032) & (t) Table 23. Global Mesalazine API Sales Volume Share by Type (2021-2026) Table 24. Global Mesalazine API Sales Volume Share by Type (2027-2032) Table 25. Global Mesalazine API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Mesalazine API Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Mesalazine API Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Mesalazine API Sales Value Share by Type (2021-2026) Table 29. Global Mesalazine API Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Suppository Table 31. Significant Companies of Tablets Table 32. Significant Companies of Granule Table 33. Significant Companies of Capsules Table 34. Significant Companies of Enema Table 35. Significant Companies of Others Table 36. Global Mesalazine API Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 37. Global Mesalazine API Sales Volume by Application (2021-2026) & (t) Table 38. Global Mesalazine API Sales Volume by Application (2027-2032) & (t) Table 39. Global Mesalazine API Sales Volume Share by Application (2021-2026) Table 40. Global Mesalazine API Sales Volume Share by Application (2027-2032) Table 41. Global Mesalazine API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Mesalazine API Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Mesalazine API Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Mesalazine API Sales Value Share by Application (2021-2026) Table 45. Global Mesalazine API Sales Value Share by Application (2027-2032) Table 46. Global Mesalazine API Sales by Region: 2021 VS 2025 VS 2032 (t) Table 47. Global Mesalazine API Sales by Region (2021-2026) & (t) Table 48. Global Mesalazine API Sales Market Share by Region (2021-2026) Table 49. Global Mesalazine API Sales by Region (2027-2032) & (t) Table 50. Global Mesalazine API Sales Market Share by Region (2027-2032) Table 51. Global Mesalazine API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Mesalazine API Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Mesalazine API Sales Value Share by Region (2021-2026) Table 54. Global Mesalazine API Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Mesalazine API Sales Value Share by Region (2027-2032) Table 56. Global Mesalazine API Market Average Price (USD/kg) by Region (2021-2026) Table 57. Global Mesalazine API Market Average Price (USD/kg) by Region (2027-2032) Table 58. Global Mesalazine API Sales by Country: 2021 VS 2025 VS 2032 (t) Table 59. Global Mesalazine API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Mesalazine API Sales by Country (2021-2026) & (t) Table 61. Global Mesalazine API Sales Market Share by Country (2021-2026) Table 62. Global Mesalazine API Sales by Country (2027-2032) & (t) Table 63. Global Mesalazine API Sales Market Share by Country (2027-2032) Table 64. Global Mesalazine API Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Mesalazine API Sales Value Market Share by Country (2021-2026) Table 66. Global Mesalazine API Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Mesalazine API Sales Value Market Share by Country (2027-2032) Table 68. YC Biotech (Jiangsu) Company Information Table 69. YC Biotech (Jiangsu) Business Overview Table 70. YC Biotech (Jiangsu) Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 71. YC Biotech (Jiangsu) Mesalazine API Product Portfolio Table 72. YC Biotech (Jiangsu) Recent Development Table 73. Lianyungang Fengheng Biopharm Company Information Table 74. Lianyungang Fengheng Biopharm Business Overview Table 75. Lianyungang Fengheng Biopharm Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 76. Lianyungang Fengheng Biopharm Mesalazine API Product Portfolio Table 77. Lianyungang Fengheng Biopharm Recent Development Table 78. Hangzhou Brother Company Information Table 79. Hangzhou Brother Business Overview Table 80. Hangzhou Brother Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 81. Hangzhou Brother Mesalazine API Product Portfolio Table 82. Hangzhou Brother Recent Development Table 83. Syntese A/S Company Information Table 84. Syntese A/S Business Overview Table 85. Syntese A/S Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 86. Syntese A/S Mesalazine API Product Portfolio Table 87. Syntese A/S Recent Development Table 88. PharmaZell Company Information Table 89. PharmaZell Business Overview Table 90. PharmaZell Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 91. PharmaZell Mesalazine API Product Portfolio Table 92. PharmaZell Recent Development Table 93. Lasa Loboratory Company Information Table 94. Lasa Loboratory Business Overview Table 95. Lasa Loboratory Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 96. Lasa Loboratory Mesalazine API Product Portfolio Table 97. Lasa Loboratory Recent Development Table 98. Ishita Active Pharma Ingredients Company Information Table 99. Ishita Active Pharma Ingredients Business Overview Table 100. Ishita Active Pharma Ingredients Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 101. Ishita Active Pharma Ingredients Mesalazine API Product Portfolio Table 102. Ishita Active Pharma Ingredients Recent Development Table 103. Ipca Laboratories Company Information Table 104. Ipca Laboratories Business Overview Table 105. Ipca Laboratories Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 106. Ipca Laboratories Mesalazine API Product Portfolio Table 107. Ipca Laboratories Recent Development Table 108. Erregierre SpA Company Information Table 109. Erregierre SpA Business Overview Table 110. Erregierre SpA Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 111. Erregierre SpA Mesalazine API Product Portfolio Table 112. Erregierre SpA Recent Development Table 113. Divis Laboratories Company Information Table 114. Divis Laboratories Business Overview Table 115. Divis Laboratories Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 116. Divis Laboratories Mesalazine API Product Portfolio Table 117. Divis Laboratories Recent Development Table 118. CTX Lifescience Company Information Table 119. CTX Lifescience Business Overview Table 120. CTX Lifescience Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 121. CTX Lifescience Mesalazine API Product Portfolio Table 122. CTX Lifescience Recent Development Table 123. Corden Pharma Bergamo Company Information Table 124. Corden Pharma Bergamo Business Overview Table 125. Corden Pharma Bergamo Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 126. Corden Pharma Bergamo Mesalazine API Product Portfolio Table 127. Corden Pharma Bergamo Recent Development Table 128. Chemi SpA Company Information Table 129. Chemi SpA Business Overview Table 130. Chemi SpA Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 131. Chemi SpA Mesalazine API Product Portfolio Table 132. Chemi SpA Recent Development Table 133. Cambrex Corporation Company Information Table 134. Cambrex Corporation Business Overview Table 135. Cambrex Corporation Mesalazine API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 136. Cambrex Corporation Mesalazine API Product Portfolio Table 137. Cambrex Corporation Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Mesalazine API Distributors List Table 141. Mesalazine API Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Mesalazine API Product Image Figure 2. Global Mesalazine API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalazine API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mesalazine API Sales (2021-2032) & (t) Figure 5. Global Mesalazine API Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Mesalazine API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥ 99% Image Figure 10. Purity ≥ 98% Image Figure 11. Purity ≥ 97% Image Figure 12. Global Mesalazine API Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Mesalazine API Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Mesalazine API Sales Volume Share by Type (2021-2032) Figure 15. Global Mesalazine API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Mesalazine API Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Mesalazine API Sales Value Share by Type (2021-2032) Figure 18. Suppository Image Figure 19. Tablets Image Figure 20. Granule Image Figure 21. Capsules Image Figure 22. Enema Image Figure 23. Others Image Figure 24. Global Mesalazine API Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 25. Global Mesalazine API Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Mesalazine API Sales Volume Share by Application (2021-2032) Figure 27. Global Mesalazine API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Mesalazine API Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Mesalazine API Sales Value Share by Application (2021-2032) Figure 30. Global Mesalazine API Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 31. Global Mesalazine API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Mesalazine API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Mesalazine API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Mesalazine API Sales Value (2021-2032) & (US$ Million) Figure 35. North America Mesalazine API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Mesalazine API Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Mesalazine API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Mesalazine API Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Mesalazine API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Mesalazine API Sales Value (2021-2032) & (US$ Million) Figure 41. South America Mesalazine API Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Mesalazine API Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Mesalazine API Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Mesalazine API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Mesalazine API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Mesalazine API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Mesalazine API Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Mesalazine API Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 99%
  • Purity ≥ 98%
  • Purity ≥ 97%
Applications
  • Suppository
  • Tablets
  • Granule
  • Capsules
  • Enema
  • Others
Companies covered
  • YC Biotech (Jiangsu)
  • Lianyungang Fengheng Biopharm
  • Hangzhou Brother
  • Syntese A/S
  • PharmaZell
  • Lasa Loboratory
  • Ishita Active Pharma Ingredients
  • Ipca Laboratories
  • Erregierre SpA
  • Divis Laboratories
  • CTX Lifescience
  • Corden Pharma Bergamo
  • Chemi SpA
  • Cambrex Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalazine API Sales Value (2021-2032)
  4. 1.2.2 Global Mesalazine API Sales Volume (2021-2032)
  5. 1.2.3 Global Mesalazine API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mesalazine API Market Dynamics
  1. 2.1 Mesalazine API Industry Trends
  2. 2.2 Mesalazine API Industry Drivers
  3. 2.3 Mesalazine API Industry Opportunities and Challenges
  4. 2.4 Mesalazine API Industry Restraints
3 Mesalazine API Market by Company
  1. 3.1 Global Mesalazine API Company Revenue Ranking in 2025
  2. 3.2 Global Mesalazine API Revenue by Company (2021-2026)
  3. 3.3 Global Mesalazine API Sales Volume by Company (2021-2026)
  4. 3.4 Global Mesalazine API Average Price by Company (2021-2026)
  5. 3.5 Global Mesalazine API Company Ranking (2024-2026)
  6. 3.6 Global Mesalazine API Company Manufacturing Base and Headquarters
  7. 3.7 Global Mesalazine API Company Product Type and Application
  8. 3.8 Global Mesalazine API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mesalazine API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mesalazine API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mesalazine API Market by Type
  1. 4.1 Mesalazine API Type Introduction
  2. 4.1.1 Purity ≥ 99%
  3. 4.1.2 Purity ≥ 98%
  4. 4.1.3 Purity ≥ 97%
  5. 4.2 Global Mesalazine API Sales Volume by Type
  6. 4.2.1 Global Mesalazine API Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Mesalazine API Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Mesalazine API Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Mesalazine API Sales Value by Type
  10. 4.3.1 Global Mesalazine API Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Mesalazine API Sales Value by Type (2021-2032)
  12. 4.3.3 Global Mesalazine API Sales Value Share by Type (2021-2032)
5 Mesalazine API Market by Application
  1. 5.1 Mesalazine API Application Introduction
  2. 5.1.1 Suppository
  3. 5.1.2 Tablets
  4. 5.1.3 Granule
  5. 5.1.4 Capsules
  6. 5.1.5 Enema
  7. 5.1.6 Others
  8. 5.2 Global Mesalazine API Sales Volume by Application
  9. 5.2.1 Global Mesalazine API Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Mesalazine API Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Mesalazine API Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Mesalazine API Sales Value by Application
  13. 5.3.1 Global Mesalazine API Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Mesalazine API Sales Value by Application (2021-2032)
  15. 5.3.3 Global Mesalazine API Sales Value Share by Application (2021-2032)
6 Mesalazine API Regional Sales and Value Analysis
  1. 6.1 Global Mesalazine API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mesalazine API Sales by Region (2021-2032)
  3. 6.2.1 Global Mesalazine API Sales by Region: 2021-2026
  4. 6.2.2 Global Mesalazine API Sales by Region (2027-2032)
  5. 6.3 Global Mesalazine API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mesalazine API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mesalazine API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mesalazine API Sales Value by Region (2027-2032)
  9. 6.5 Global Mesalazine API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mesalazine API Sales Value (2021-2032)
  12. 6.6.2 North America Mesalazine API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mesalazine API Sales Value (2021-2032)
  15. 6.7.2 Europe Mesalazine API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mesalazine API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mesalazine API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mesalazine API Sales Value (2021-2032)
  21. 6.9.2 South America Mesalazine API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mesalazine API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mesalazine API Sales Value Share by Country, 2025 VS 2032
7 Mesalazine API Country-level Sales and Value Analysis
  1. 7.1 Global Mesalazine API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mesalazine API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mesalazine API Sales by Country (2021-2032)
  4. 7.3.1 Global Mesalazine API Sales by Country (2021-2026)
  5. 7.3.2 Global Mesalazine API Sales by Country (2027-2032)
  6. 7.4 Global Mesalazine API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mesalazine API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mesalazine API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mesalazine API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mesalazine API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mesalazine API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mesalazine API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mesalazine API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mesalazine API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mesalazine API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mesalazine API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mesalazine API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mesalazine API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mesalazine API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mesalazine API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mesalazine API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mesalazine API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mesalazine API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mesalazine API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mesalazine API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mesalazine API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mesalazine API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mesalazine API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mesalazine API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mesalazine API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mesalazine API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mesalazine API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mesalazine API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mesalazine API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mesalazine API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mesalazine API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mesalazine API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mesalazine API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mesalazine API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mesalazine API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mesalazine API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mesalazine API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mesalazine API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mesalazine API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mesalazine API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mesalazine API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mesalazine API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mesalazine API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mesalazine API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mesalazine API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mesalazine API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mesalazine API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mesalazine API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mesalazine API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mesalazine API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mesalazine API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mesalazine API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mesalazine API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mesalazine API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mesalazine API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mesalazine API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mesalazine API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mesalazine API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mesalazine API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mesalazine API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mesalazine API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mesalazine API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mesalazine API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mesalazine API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mesalazine API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mesalazine API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mesalazine API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mesalazine API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mesalazine API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mesalazine API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mesalazine API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mesalazine API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mesalazine API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mesalazine API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mesalazine API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mesalazine API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mesalazine API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mesalazine API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mesalazine API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mesalazine API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mesalazine API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mesalazine API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mesalazine API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mesalazine API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mesalazine API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mesalazine API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mesalazine API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 YC Biotech (Jiangsu)
  2. 8.1.1 YC Biotech (Jiangsu) Company Information
  3. 8.1.2 YC Biotech (Jiangsu) Business Overview
  4. 8.1.3 YC Biotech (Jiangsu) Mesalazine API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 YC Biotech (Jiangsu) Mesalazine API Product Portfolio
  6. 8.1.5 YC Biotech (Jiangsu) Recent Developments
  7. 8.2 Lianyungang Fengheng Biopharm
  8. 8.2.1 Lianyungang Fengheng Biopharm Company Information
  9. 8.2.2 Lianyungang Fengheng Biopharm Business Overview
  10. 8.2.3 Lianyungang Fengheng Biopharm Mesalazine API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lianyungang Fengheng Biopharm Mesalazine API Product Portfolio
  12. 8.2.5 Lianyungang Fengheng Biopharm Recent Developments
  13. 8.3 Hangzhou Brother
  14. 8.3.1 Hangzhou Brother Company Information
  15. 8.3.2 Hangzhou Brother Business Overview
  16. 8.3.3 Hangzhou Brother Mesalazine API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hangzhou Brother Mesalazine API Product Portfolio
  18. 8.3.5 Hangzhou Brother Recent Developments
  19. 8.4 Syntese A/S
  20. 8.4.1 Syntese A/S Company Information
  21. 8.4.2 Syntese A/S Business Overview
  22. 8.4.3 Syntese A/S Mesalazine API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Syntese A/S Mesalazine API Product Portfolio
  24. 8.4.5 Syntese A/S Recent Developments
  25. 8.5 PharmaZell
  26. 8.5.1 PharmaZell Company Information
  27. 8.5.2 PharmaZell Business Overview
  28. 8.5.3 PharmaZell Mesalazine API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 PharmaZell Mesalazine API Product Portfolio
  30. 8.5.5 PharmaZell Recent Developments
  31. 8.6 Lasa Loboratory
  32. 8.6.1 Lasa Loboratory Company Information
  33. 8.6.2 Lasa Loboratory Business Overview
  34. 8.6.3 Lasa Loboratory Mesalazine API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lasa Loboratory Mesalazine API Product Portfolio
  36. 8.6.5 Lasa Loboratory Recent Developments
  37. 8.7 Ishita Active Pharma Ingredients
  38. 8.7.1 Ishita Active Pharma Ingredients Company Information
  39. 8.7.2 Ishita Active Pharma Ingredients Business Overview
  40. 8.7.3 Ishita Active Pharma Ingredients Mesalazine API Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ishita Active Pharma Ingredients Mesalazine API Product Portfolio
  42. 8.7.5 Ishita Active Pharma Ingredients Recent Developments
  43. 8.8 Ipca Laboratories
  44. 8.8.1 Ipca Laboratories Company Information
  45. 8.8.2 Ipca Laboratories Business Overview
  46. 8.8.3 Ipca Laboratories Mesalazine API Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ipca Laboratories Mesalazine API Product Portfolio
  48. 8.8.5 Ipca Laboratories Recent Developments
  49. 8.9 Erregierre SpA
  50. 8.9.1 Erregierre SpA Company Information
  51. 8.9.2 Erregierre SpA Business Overview
  52. 8.9.3 Erregierre SpA Mesalazine API Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Erregierre SpA Mesalazine API Product Portfolio
  54. 8.9.5 Erregierre SpA Recent Developments
  55. 8.10 Divis Laboratories
  56. 8.10.1 Divis Laboratories Company Information
  57. 8.10.2 Divis Laboratories Business Overview
  58. 8.10.3 Divis Laboratories Mesalazine API Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Divis Laboratories Mesalazine API Product Portfolio
  60. 8.10.5 Divis Laboratories Recent Developments
  61. 8.11 CTX Lifescience
  62. 8.11.1 CTX Lifescience Company Information
  63. 8.11.2 CTX Lifescience Business Overview
  64. 8.11.3 CTX Lifescience Mesalazine API Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CTX Lifescience Mesalazine API Product Portfolio
  66. 8.11.5 CTX Lifescience Recent Developments
  67. 8.12 Corden Pharma Bergamo
  68. 8.12.1 Corden Pharma Bergamo Company Information
  69. 8.12.2 Corden Pharma Bergamo Business Overview
  70. 8.12.3 Corden Pharma Bergamo Mesalazine API Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Corden Pharma Bergamo Mesalazine API Product Portfolio
  72. 8.12.5 Corden Pharma Bergamo Recent Developments
  73. 8.13 Chemi SpA
  74. 8.13.1 Chemi SpA Company Information
  75. 8.13.2 Chemi SpA Business Overview
  76. 8.13.3 Chemi SpA Mesalazine API Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Chemi SpA Mesalazine API Product Portfolio
  78. 8.13.5 Chemi SpA Recent Developments
  79. 8.14 Cambrex Corporation
  80. 8.14.1 Cambrex Corporation Company Information
  81. 8.14.2 Cambrex Corporation Business Overview
  82. 8.14.3 Cambrex Corporation Mesalazine API Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Cambrex Corporation Mesalazine API Product Portfolio
  84. 8.14.5 Cambrex Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mesalazine API Value Chain Analysis
  2. 9.1.1 Mesalazine API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mesalazine API Sales Mode & Process
  6. 9.2 Mesalazine API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mesalazine API Distributors
  9. 9.2.3 Mesalazine API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst